Position in JNJ
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$228,065
+$8,803 QoQ
Shares Held
898
+0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#4,409
of 4,664 holders
Holding Since
Jun 2024
9 quarters on record
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Financial Network Wealth Advisors LLC holds $2,004,784 across 12 Drug Manufacturers - General names. JNJ ranks #3 (11.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
3,850 | $968,814 | |
| 2 | NVO |
Novo Nordisk A S
|
4,942 | $236,919 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
898 | $228,065 | |
| 4 | LLY |
ELI LILLY & Co
|
143 | $171,518 | |
| 5 | PFE |
Pfizer Inc
|
6,438 | $155,027 | |
| 6 | MRK |
Merck & Co., Inc.
|
487 | $62,579 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
939 | $54,105 | |
| 8 | NVS |
Novartis AG
|
334 | $52,344 |
All Filings in JNJ
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $228,065 | 898 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $219,262 | 897 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $221,436 | 1,070 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $200,809 | 1,083 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $177,037 | 1,159 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $198,012 | 1,194 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $107,597 | 744 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $206,950 | 1,277 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $208,713 | 1,428 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||